Elevated soluble fas production in SLE correlates with HLA status not with disease activity

Lupus

Volumn 6, Issue 9, 1997, Pages 717-722

  Rose, L M ^a   Latchman, D S ^a   Isenberg, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Fas; Systemic lupus erythematosus

Indexed keywords

FAS ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030829920     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600907     Document Type: Article

References (34)

1. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989, 169: 1747-1756.
2. Trauth BC, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 1989; 245: 301-304.
3. Itoh N et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
4. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
5. Miyawaki T et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753-3758.
6. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
7. Ju S-T et al Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-448.
8. Watanabe-Fukunaga R et al. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1279.
9. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of 1pr mice. Proc Natl Acad Sci USA 1993; 90: 1756-1760.
10. Cohen PL, Eisenberg DA. Ipr and gld single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991; 9: 243-269.
11. Takahashi et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
12. 2+-independent T cell mediated cytotoxicity. J Exp Med 1993; 177: 195-200.
13. Cheng J et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
14. Glinski W, Gershwin ME, Budman D, Steinberg D. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin Exp Immunol 1976; 26: 228-238.
15. Theofilopoulos AN, Dixon FW. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269-390.
16. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
17. Hay EM et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Quart J Med 1993; 86: 447-458.
18. Gladman DD et al. Sensitivity to change of three systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994; 21: 1468-1471.
19. Arnett FC et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
20. Worrall J, Snaith M, Batchelor R, Isenberg DA. Systemic lupus erythematosus a rheumatological review. Quart J Med 1990; 275: 315-330.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 1987; 162: 156-159.
22. Cavicchioli L et al. Choline-acetyltransferase messenger RNA expression in developing and adult rat brain regulation by nerve growth factor. Mol Brain Res 1991; 8: 319-325.
23. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Anti-Fas on nonhemotopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological response. Cancer Res 1997; 54: 1580-1586.
24. Goel N et al. Lack of correlation between serum soluble Fas/Apo-1 levels and autoimmune disease. Arthritis Rheum 1995; 12: 1738-1743
25. Kipping E, Krammer PH, Orel KB, Lehman TJA, Mysler E, Elkon KB Levels of soluble Fas/Apo-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum 1995; 12: 1735-1737
26. Jodo S et al. Serum levels of soluble Fas/Apo-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immunol 1997; 107: 89-95.
27. Takano Y et al. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus. J Clin Immunol 1996; 16: 261-265.
28. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S. Expression and function of Fas antigen and bcl-2 in human systemic erythematosus lupus lymphocytes. Clin Immunol Immunopathol 1994; 73: 109-114.
29. Mysler E et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93: 1029-1034.
30. Smith CA et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019-1023.
31. Basu A, Raghunath M, Bishayee S, Das M. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 1983; 9: 671-677.
32. Alderson MR et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178: 2231-2235.
33. Cascino I et al. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995; 154: 2706-2713.
34. Rose LM, Latchman DS, Isenberg DA. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review. Brit J Rheum 1997; 36: 158-163.